The Asia Pacific influenza vaccines market is expected to grow from US$ 1,688.07 million in 2022 to US$ 2,669.27 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2022 to 2028.
Emerging Economies to Fuel Asia Pacific Influenza Vaccines Market
Leading players in the Asia Pacific influenza vaccines market focus on expanding their customer reach across emerging markets by expanding their distribution networks and augmenting their manufacturing capabilities. With the maturing of the region, players are shifting their focus to emerging economies. Due to less stringent regulations and data requirements, Asia Pacific has become a business-friendly and adaptable hub. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in upgrading the latest technologies in developing countries, which supports the inclination toward advanced vaccine development. Key producers of influenza vaccines in India and South Korea are expected to witness lucrative opportunities in the coming years due to the large patient pool and high prevalence of influenza, surge in healthcare infrastructure, rise in disposable income, and the surge of medical tourism in these countries.Asia Pacific Influenza Vaccines Market Overview
Asia Pacific (APAC) is the fastest-growing regional market for influenza vaccines. The Asia Pacific influenza vaccines market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. Owing to the increase in government support and surveillance regarding vaccination against influenza, rise in investment by leading market players across the region, and increase in prevalence and incidence of influenza in this region. These factors are expected to propel the Asia Pacific influenza vaccines market in the coming years.Asia Pacific Influenza Vaccines Market Segmentation
The Asia Pacific influenza vaccines market is segmented into vaccine type, virus type, technology, route of administration, target group, and country.- Based on vaccine type, the Asia Pacific influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.
- Based on virus type, the Asia Pacific influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.
- Based on technology, the Asia Pacific influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.
- Based on route of administration, the Asia Pacific influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.
- Based on target group, the Asia Pacific influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.
- Based on country, the Asia Pacific influenza vaccines market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the market in 2022.
Table of Contents
1. Introduction1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Influenza Vaccines Market - By Vaccine Type
1.3.2 Asia Pacific Influenza Vaccines Market - By Virus Type
1.3.3 Asia Pacific Influenza Vaccines Market - By Technology
1.3.4 Asia Pacific Influenza Vaccines Market - By Route of Administration
1.3.5 Asia Pacific Influenza Vaccines Market - By Target Group
1.3.6 Asia Pacific Influenza Vaccines Market - By Country
2. Asia Pacific Influenza Vaccines Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Influenza Vaccines Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Influenza Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Government Support to Promote Influenza Vaccination
5.1.2 Increasing Investment by Top Market Players and Governments
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Economies
5.4 Future Trends
5.4.1 Strong Pipeline Candidates for Influenza Vaccines
5.5 Impact Analysis
6. Influenza Vaccine Market - Asia Pacific Analysis
6.1 Asia Pacific Influenza Vaccines Market, By Country - Forecasts And Analysis
6.2 Asia Pacific Influenza Vaccines Market Revenue Forecasts And Analysis
6.2.1 Asia Pacific : Influenza Vaccines Market, 2019-2028 (US$ Million)
7. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type
7.1 Overview
7.2 Asia Pacific Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
7.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
7.3 Quadrivalent Vaccines
7.3.1 Overview
7.3.2 Quadrivalent Vaccines : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Trivalent Vaccines
7.4.1 Overview
7.4.2 Trivalent Vaccines : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type
8.1 Overview
8.2 Asia Pacific Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
8.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
8.3 Influenza Virus Type A
8.3.1 Overview
8.3.2 Influenza Virus Type A : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Influenza Virus Type B
8.4.1 Overview
8.4.2 Influenza Virus Type B : Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology
9.1 Overview
9.2 Asia Pacific Influenza Vaccines Market, By Technology 2022 & 2028 (%)
9.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
9.3 Egg-based
9.3.1 Overview
9.3.2 Egg-based : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Cell-based
9.4.1 Overview
9.4.2 Cell-based : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration
10.1 Overview
10.2 Asia Pacific Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
10.2.1 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
10.3 Injection
10.3.1 Overview
10.3.2 Injection : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Nasal Spray
10.4.1 Overview
10.4.2 Nasal Spray: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group
11.1 Overview
11.2 Asia Pacific Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
11.2.1 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
11.3 Infants
11.3.1 Overview
11.3.2 Infants : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Children
11.4.1 Overview
11.4.2 Children: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Adults
11.5.1 Overview
11.5.2 Adults : Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Elderly People
11.6.1 Overview
11.6.2 Elderly People: Asia Pacific Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
12. Asia Pacific Influenza Vaccines Market Analysis and Forecasts To 2028 - Country Analysis
12.1 Asia Pacific: Influenza Vaccines Market
12.1.1 Overview
12.1.3 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
12.1.3.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.1.1 Overview
12.1.3.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.2.1 Overview
12.1.3.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.2.7 China: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.3.1 Overview
12.1.3.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.3.7 India: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.4.1 Overview
12.1.3.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.5.1 Overview
12.1.3.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
12.1.3.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
12.1.3.6 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.3.6.1 Overview
12.1.3.6.2 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
12.1.3.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
12.1.3.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
12.1.3.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
12.1.3.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
12.1.3.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
13. Asia Pacific Influenza Vaccine Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Moderna, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 SEQIRUS
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Hualan Biological Engineering Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Emergent BioSolutions Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Mitsubishi Chemical Group Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt. Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 MYLAN N.V.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 AstraZeneca
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
Table 1. Asia Pacific Influenza Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
Table 3. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 4. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 5. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
Table 6. Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 8. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 9. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 10. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 11. Japan Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 12. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 13. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 14. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 15. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 16. China Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 17. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 18. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 19. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 20. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 21. India Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 22. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 23. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 24. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 25. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 26. South Korea Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 27. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 28. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 29. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 30. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 31. Australia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
Table 33. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
Table 34. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 35. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
Table 36. Rest of Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
Table 37. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
Table 38. Recent Organic Growth Strategies in the Influenza Vaccine Market
Table 39. Glossary of Terms, Influenza Vaccines Market
Figure 1. Asia Pacific Influenza Vaccines Market Segmentation
Figure 2. Asia Pacific Influenza Vaccines Market Segmentation, by Country
Figure 3. Asia Pacific Influenza Vaccines Market Overview
Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Asia Pacific Influenza Vaccines Market
Figure 5. China Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Asia Pacific Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
Figure 9. Asia Pacific Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
Figure 10. Quadrivalent Vaccines: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Trivalent Vaccines: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Asia Pacific Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
Figure 13. Influenza Virus Type A : Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Influenza Virus Type B: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Asia Pacific Influenza Vaccines Market, by Technology 2022 & 2028 (%)
Figure 16. Egg-based: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Cell-based: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. Asia Pacific Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
Figure 19. Injection: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Nasal Spray: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Asia Pacific Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
Figure 22. Infants : Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Children: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Adults: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Elderly People: Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
Figure 27. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
Figure 28. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Growth Strategies in the Influenza Vaccine Market, 2021-2028
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca
- Emergent BioSolutions Inc.
- GlaxoSmithKline plc.
- Hualan Biological Engineering Inc.
- Mitsubishi Chemical Group Corporation
- Moderna, Inc.
- MYLAN N.V.
- Sanofi
- SEQIRUS
- Serum Institute of India Pvt. Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 166 |
| Published | January 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1688.07 Million |
| Forecasted Market Value ( USD | $ 2669.27 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Asia Pacific |
